These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 17144663

  • 41. Essential role of extracellular charged residues of the human CCK(1) receptor for interactions with SR 146131, SR 27897 and CCK-8S.
    Gouldson P, Legoux P, Carillon C, Dumont X, Le Fur G, Ferrara P, Shire D.
    Eur J Pharmacol; 2000 Feb 18; 389(2-3):115-24. PubMed ID: 10688974
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Constitutive formation of oligomeric complexes between family B G protein-coupled vasoactive intestinal polypeptide and secretin receptors.
    Harikumar KG, Morfis MM, Lisenbee CS, Sexton PM, Miller LJ.
    Mol Pharmacol; 2006 Jan 18; 69(1):363-73. PubMed ID: 16244179
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Cholecystokinin peptides and receptor binding in Alzheimer's disease.
    Löfberg C, Harro J, Gottfries CG, Oreland L.
    J Neural Transm (Vienna); 1996 Jan 18; 103(7):851-60. PubMed ID: 8872869
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
    Holst B, Lang M, Brandt E, Bach A, Howard A, Frimurer TM, Beck-Sickinger A, Schwartz TW.
    Mol Pharmacol; 2006 Sep 18; 70(3):936-46. PubMed ID: 16798937
    [Abstract] [Full Text] [Related]

  • 52. Monitoring the state of cholecystokinin receptor oligomerization after ligand binding using decay of time-resolved fluorescence anisotropy.
    Harikumar KG, Miller LJ.
    Ann N Y Acad Sci; 2008 Nov 18; 1144():21-7. PubMed ID: 19076359
    [Abstract] [Full Text] [Related]

  • 53. Secretin receptor oligomers form intracellularly during maturation through receptor core domains.
    Lisenbee CS, Miller LJ.
    Biochemistry; 2006 Jul 11; 45(27):8216-26. PubMed ID: 16819820
    [Abstract] [Full Text] [Related]

  • 54. Insights into the molecular basis of ligand binding by the cholecystokinin receptor.
    Miller LJ, Ding XQ.
    Pancreatology; 2001 Jul 11; 1(4):336-42. PubMed ID: 12120212
    [Abstract] [Full Text] [Related]

  • 55. Identical primary sequence but different conformations of the bioactive regions of canine CCK-8 and CCK-58.
    Keire DA, Solomon TE, Reeve JR.
    Biochem Biophys Res Commun; 1999 Dec 20; 266(2):400-4. PubMed ID: 10600515
    [Abstract] [Full Text] [Related]

  • 56. Identification of membrane insertion sequences of the rabbit gastric cholecystokinin-A receptor by in vitro translation.
    Bayle D, Weeks D, Sachs G.
    J Biol Chem; 1997 Aug 08; 272(32):19697-707. PubMed ID: 9242625
    [Abstract] [Full Text] [Related]

  • 57. Elucidation of the molecular basis of cholecystokinin Peptide docking to its receptor using site-specific intrinsic photoaffinity labeling and molecular modeling.
    Dong M, Lam PC, Pinon DI, Abagyan R, Miller LJ.
    Biochemistry; 2009 Jun 16; 48(23):5303-12. PubMed ID: 19441839
    [Abstract] [Full Text] [Related]

  • 58. Determination of ligand-receptor interactions of cholecystokinin by nuclear magnetic resonance.
    Giragossian C, Mierke DF.
    Life Sci; 2003 Jun 27; 73(6):705-13. PubMed ID: 12801592
    [Abstract] [Full Text] [Related]

  • 59. Refinement of the conformation of a critical region of charge-charge interaction between cholecystokinin and its receptor.
    Ding XQ, Pinon DI, Furse KE, Lybrand TP, Miller LJ.
    Mol Pharmacol; 2002 May 27; 61(5):1041-52. PubMed ID: 11961122
    [Abstract] [Full Text] [Related]

  • 60. Disruption of Rhodopsin Dimerization with Synthetic Peptides Targeting an Interaction Interface.
    Jastrzebska B, Chen Y, Orban T, Jin H, Hofmann L, Palczewski K.
    J Biol Chem; 2015 Oct 16; 290(42):25728-44. PubMed ID: 26330551
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.